Press Releases Archive
- Pantec Biosolutions reports first successful IVF pregnancy using P.L.E.A.S.E.® -FSH patch
- Pantec Biosolutions Achieves Clinical Efficacy POC for Delivery of urinary FSH using P.L.E.A.S.E.®
- Pantec Biosolutions receives "Honourable Mention" in red dot awards
- Pantec Biosolutions Closes CHF 20 Million Financing
- Pantec Biosolutions' P.L.E.A.S.E. Professional® Receives Marketing Authorisation
- Pantec Biosolutions reports successful Phase I for delivery of FSH using P.L.E.A.S.E.®
- Pantec Biosolutions is Granted SME Status in EU
- Pantec Biosolutions Granted European Patent for P.L.E.A.S.E.®
- Pantec Biosolutions reports successful Phase I study into the delivery of triptorelin using P.L.E.A.S.E.® technology
- Pantec Biosolutions Expands Scientific Advisory Board
- Pantec Biosolutions Receives Marketing Clearance for P.L.E.A.S.E.®
- Pantec Biosolutions receives ISO 13485 certification
- Pantec Biosolutions appoints new Board members
- Pantec Biosolutions unveils preclinical data for novel transdermal drug delivery platform
- Pantec Biosolutions presented new drug delivery platform and supporting preclinical data at Drug Delivery Partnerships 2008
- Pantec Biosolutions successfully initiates Series A Financing Round
- New web animation showing how the P.L.E.A.S.E.® platform works
- Nomination for Swiss Medtech Award 2007
- Human cutaneous tolerability study concluded positively
